Results 161 to 170 of about 8,771 (219)

Successful treatment of severe retroauricular pyoderma gangrenosum with upadacitinib in a patient with Crohn's disease and a history of cerebral venous sinus thrombosis. [PDF]

Ther Adv Gastroenterol
Fousekis F, Ronicke M, Sollfrank L, Rech J, Berking C, Neurath MF, Sticherling M, Atreya R.   +7 more
europepmc   +1 more source

Real-World Effectiveness and Safety of Abrocitinib in Patients with Atopic Dermatitis: A 16-Week Single-Center Retrospective Cohort Study Compared with Upadacitinib and Baricitinib. [PDF]

Dermatol Ther (Heidelb)
Gwag HE, Park M, Park SY, Hong N, Heo SJ, Jung HJ, Park MY, Choi YS, Ahn J.   +8 more
europepmc   +1 more source

Optimal use and cycling strategies of Janus kinase inhibitors in ulcerative colitis: current evidence and clinical implications from the KASID Guidelines Task Force Team. [PDF]

Intest Res
Hong SM, Kim DH, Bae JH, Shin SY, Song EM, Kim JE, Yang YJ, Yoon J, Kang SB, Kim ES, Kim SE, Kim SJ, Lee J, Na SY, Park SJ, Park SH, Choi M, Kim MH, Moon W, Jung SA.   +19 more
europepmc   +1 more source

P313 Impact of upadacitinib on the general clinical condition of patients with Crohn’s disease (CD): data from the randomised CELEST study [PDF]

, 2019
Goteti, S, Lacerda, A, Loftus, EV, Panes, J, Pugatch, D, Rubin, DT, Travis, Simon, Zhou, W   +7 more
core   +2 more sources

Review of Herpes Zoster Occurrence in Patients With Atopic Dermatitis Treated With JAK Inhibitors. [PDF]

Clin Transl Sci
Mandecka A, Perlak K, Bajek W, Kruczek W, Frątczak A, Polak K, Miziołek B, Bergler-Czop B.   +7 more
europepmc   +1 more source

Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study [PDF]

Capassoni, Marco, Cometi, Laura, Guiducci, Serena, Nacci, Francesca   +3 more
core   +1 more source

Upadacitinib for Atopic Dermatitis Involving Special and Sensitive Areas: Real-World Multicenter Outcomes in Hand, Head/Neck, and Genital Involvement. [PDF]

Dermatol Ther (Heidelb)
Melgosa Ramos FJ, Guillén-Climent S, Cavestany Rodriguez R, Sabater-Abad J, Martorell A, Tous Romero F.   +5 more
europepmc   +1 more source

Safety and efficacy of different JAK inhibitors in the treatment of inflammatory bowel disease: a network meta-analysis. [PDF]

Front Pharmacol
Wu H, Zhou Y, Chen X, Wang L, Guo Y, Du X, Miao X.   +6 more
europepmc   +1 more source

Beneficial effects of upadacitinib on a subgroup of patients with atopic dermatitis and hidradenitis suppurativa: a multicenter, real-world retrospective study. [PDF]

Front Immunol
Russo F, Schettini N, Scaglione GL, Gori N, Manzo Margiotta F, Del Duca E, Bianchelli T, Calabrese L, Antonelli E, Giuliani F, Corbeddu M, Galluzzo M.   +11 more
europepmc   +1 more source